Business News • PR NewsWire • Cell Therapeutics, Inc. (CTI) to update Pixuvri® launch and pacritinib pivotal trial status at the Annual Rodman & Renshaw Global Investment Conference

Cell Therapeutics, Inc. (CTI) to update Pixuvri® launch and pacritinib pivotal trial status at the Annual Rodman & Renshaw Global Investment Conference

Cell Therapeutics, Inc. (CTI) to update Pixuvri® launch and pacritinib pivotal trial status at the Annual Rodman & Renshaw Global Investment Conference

SEATTLE, Sept. 7, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) management will present at the Annual Rodman & Renshaw Global Investment Conference on Tuesday, September 11 at 10:25 a.m. Eastern/ 4:25 p.m. Central European/ 7:25 a.m. Pacific...

View More : http://www.prnewswire.com/news-releases/cell-therapeutics-inc-cti-to-update-pixuvri-launch-and-pacritinib-pivotal-trial-...

Releted News by prnewswire

Broadcom® Announces NAGRA OpenTV 5 Support on Set-Top Box and Gateway Platforms

Syngenta appoints new Executive Committee member